We are live on ! Find out more
MLEC icon

Moolec Science

2 hedge funds and large institutions have $34.5K invested in Moolec Science in 2023 Q4 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 2 → 2 (0)

0% less ownership

Funds ownership: 0.04% → 0.04% (-0%)

16% less capital invested

Capital invested by funds: $41.2K → $34.5K (-$6.71K)

Holders
2
Holders Change
–
Holders Change %
0%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
-$129
2
EC
Elequin Capital
New York
-$3

MLEC Hedge Fund Activity: Q4 2023 in Review

2 of the 6,871 institutional investors tracked by Wall St. Rank reported a position in Moolec Science (MLEC) for Q4 2023, worth a combined $34.5K — down 16% from $41.2K a quarter earlier.

Fund positioning in MLEC was balanced in Q4 2023: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

The largest seller was UBS Group, cutting an estimated $129.

  • 2 institutional investors held Moolec Science (MLEC) as of Q4 2023, unchanged from Q3 2023.
  • Funds reported $34.5K of Moolec Science stock for Q4 2023, down 16% quarter-over-quarter.
  • 0 funds opened new Moolec Science positions in Q4 2023 and 0 closed out.
  • The largest Moolec Science seller in Q4 2023 was UBS Group, an estimated $129 sold.

Based on aggregated 13F filings for Q4 2023.